Ruvonoflast is an investigational new drug that is being evaluated by Nodthera for the treatment of obesity in patients with high cardiovascular risk. It is an NLRP3 inflammasome inhibitor.
The compounds of every Wikipedia article carrying a Chembox or a Drugbox, refreshed daily, with the values their infoboxes give. The pages need JavaScript; the API does not.